The future of insulin therapy

Area of Science:

• Endocrinology
• Pharmacology
• Metabolic Diseases

Background:

• Insulin therapy, established a century ago, continues to evolve.
• Current insulin formulations face challenges including hypoglycemia and weight gain.
• Ongoing research seeks to enhance insulin safety and efficacy.

Purpose of the Study:

• To review clinical data on novel insulin developments.
• To evaluate the potential of new insulin formulations for future therapy.
• To assess advancements in insulin delivery and glucose responsiveness.

Main Methods:

• Review of available clinical data for new insulin developments.
• Analysis of pre-clinical and clinical study findings.
• Evaluation of safety and efficacy profiles of emerging insulin types.

Main Results:

• Once-weekly insulin formulations demonstrate potential for improved glycemic control and reduced hypoglycemia.
• Hepato-preferential and oral insulins show proof-of-concept but require further development to address side effects and bioavailability.
• Glucose-responsive 'smart' insulins present significant potential but face considerable design challenges.

Conclusions:

• New insulin developments, including once-weekly, hepato-preferential, oral, and smart insulins, promise to significantly improve insulin therapy.
• Further research is crucial to overcome existing challenges and realize the full potential of these advanced insulin formulations.
• The continuous innovation in insulin therapy underscores a commitment to better managing diabetes and its complications.